The interaction between methylene blue and the cholinergic system

British Journal of Pharmacology

Volumn 122, Issue 1, 1997, Pages 95-98

  Pfaffendorf, M ^a   Bruning, T A ^a   Batink, H D ^a   Van Zwieten, P A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Cholinesterase; Methylene blue; Muscarinic receptors

Indexed keywords

ACETIC ACID; ACETYLCHOLINE; ACETYLCHOLINESTERASE; CHOLINESTERASE; METHYLENE BLUE; METHYLSCOPOLAMINE; MUSCARINIC RECEPTOR; NITROPHENOL;

ADULT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; ENZYME INHIBITION; HEART LEFT VENTRICLE; HUMAN; HYDROLYSIS; LIQUID SCINTILLATION COUNTING; MALE; NONHUMAN; NORMAL HUMAN; PHOTOMETRY; PLASMA; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING;

ACETYLCHOLINESTERASE; ADULT; ANIMALS; CATTLE; CHOLINESTERASE INHIBITORS; ESTERASES; HEART VENTRICLES; HUMANS; KINETICS; MALE; METHYLENE BLUE; MYOCARDIUM; N-METHYLSCOPOLAMINE; PARASYMPATHOLYTICS; PSEUDOCHOLINESTERASE; RATS; RATS, WISTAR; RECEPTORS, MUSCARINIC; SCOPOLAMINE DERIVATIVES; TRITIUM;

EID: 0030804625     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701355     Document Type: Article

References (25)

1. BRADFORD, M.M. (1976). A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
2. BRUNING, T.A., CHANG, P.C., HENDRIKS, M.G.C., VERMEIJ, P., PFAFFENDORF, M. & VAN ZWIETEN, P.A. (1995). In vivo characterization of muscarinic receptor subtypes that mediate vasodilatation in patients with essential hypertension. Hypertension, 5, 70-77.
3. BRUNING, T.A., CHANG, P.C., PFAFFENDORF, M. & VAN ZWIETEN, P.A. (1994). Methylene blue inhibits human plasma acetylcholinesterase in vivo. Can. J. Physiol. Pharmacol., 72 (suppl. 1), 111.
4. 50) of a enzymatic reaction. Biochem. Pharmacol., 22, 3099-3108.
5. DOLK, H. (1991). Methylene blue and atresia or stenosis of ileum and jejunum. Lancet, 338, 1021-1022.
6. 3-receptors. J. Pharmacol. Exp. Ther., 242, 257-262.
7. DOYLE, M.P. & HOEKSTRA, J.W. (1981). Oxidation of nitric oxides by bound dioxygen on hemoproteins. J. Inorg. Biochem., 14, 351-354.
8. EGLEN, R.M. & WHITING, R.L. (1990). Heterogeneity of vascular muscarinic receptors. J. Auton. Pharmacol., 10, 233-245.
9. GERGES, N.A., ESCHENHAGEN, T., HOVE-MADSEN, L., MÉRY, P.-F. & FISCHMEISTER, R. (1997). Methylene blue is a muscarinic antagonist in rat cardiac myocytes. Biophys. J., J72, A34.
10. HAN, X., SHIMONI, Y. & GILES, W.R. (1995) A cellular mechanism for nitric oxide-mediated cholinergic control of mammalian heart rate. J. Gen. Physiol., 106, 45-65.
11. IGNARRO, L.J., BURKE, T.M., WOOD, K.S., WOLIN, M.S. & KADOWITZ, P.J. (1984). Association between cyclic GMP accumulation and acetylcholine-elicited relaxation of bovine intrapulmonary artery. J. Pharmacol. Exp. Ther., 228, 682-690.
12. KEMME, M.J., BRUNING, T.A., CHANG, P.C. & VAN ZWIETEN, P.A. (1995). Cholinergic receptor-mediated responses in the arteriolar and venous vascular beds of the human forearm. Blood Pressure, 4, 293-299.
13. MARCZIN, N., RYAN, U.S. & CATRAVAS, J.D. (1992). Methylene blue inhibits nitrovasodilator- and endothelium-derived relaxing factor-induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion. J. Pharmacol. Exp. Ther., 263, 170-179.
14. MARSHALL, J.J., WEI, E.P. & KONTOS, H.A. (1988). Independent blockade of cerebral vasodilatation from acetylcholine and nitric oxide. Am. J. Physiol., 255, H847-H854.
15. MARTIN, W., DRAZAN, K.M. & NEWBY, A.C. (1989). Methylene blue but not changes in cyclic GMP inhibits resting and bradykinin-stimulated production of prostacyclin by pig aortic endothelial cells. Br. J. Pharmacol., 97, 51-56.
16. MARTIN, W., VILLANI, G.M., JOTHIANANDAN, D. & FURCHGOTT, R.F. (1985). Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J. Pharmacol. Exp. Ther., 232, 708-716.
17. MARTINDALE 30TH EDITION. (1993). ed. Reynolds, J.E.F. London: The Pharmaceutical Press.
18. MAYER, B., BRUNNER, F. & SCHMIDT, K. (1993). Inhibition of nitric oxide synthesis by methylene blue. Biochem. Pharmacol., 45, 367-374.
19. MCMAHON, T.J. & KADOWITZ, P.J. (1992). Methylene blue inhibits neurogenic cholinergic vasodilator responses in the pulmonary vascular bed of the cat. Am. J. Physiol., 263, L575-L584.
20. NICOLINI, V. & MONNI, G. (1990). Intestinal obstruction in babies exposed in utero to methylene blue. Lancet, 336, 1258-1259.
21. 2 synthesis in isolated dog arteries. J. Pharmacol. Exp. Ther., 254, 198-203.
22. RAPPAPORT, F., FISCHL, J. & PINTO, N. (1959). An improved method for the estimation of cholinesterase activity in serum. Clin. Chim. Acta, 4, 227-230.
23. SOARES-DA-SILVA, P. & CARAMONA, M.M. (1988). Effects of methylene blue on the uptake, release and metabolism of noradrenaline in mesenteric arterial vessels. J. Pharm. Pharmacol., 40, 534-538.
24. TSAI, S.C., ADAMIK, R., MANGANIELLO, V.C. & VAUGHAN, M. (1983). Regulation of activity of purified guanylate cyclase from liver that is unresponsive to nitric oxide. Biochem. J., 215, 447-455.
25. WOLIN, M.S., CHERRY, P.D., RODENBURY, J.M., MESSINA, E.J. & KALEY, G. (1990). Methylene blue inhibits vasodilatation of skeletal muscle arterioles to acetylcholine and nitric oxide via the extracellular generation of superoxide anion. J. Pharmacol. Exp. Ther., 254, 872-876.